Prieks Pharmaceutical Private Limited
About Prieks Pharmaceutical Private Limited
Data last updated:
Prieks Pharmaceutical Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2015PTC084003. Its GSTIN is 24AAICP2642L1ZA (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hiruben Rameshbhai Chaudhary and Shaileshbhai Hemrajbhai Chaudhary.
Its last annual general meeting (AGM) was held on 25 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 790 – 1 Parshottamnagar Opp. Mun Bus Stand Nawa Wadaj, Ahmedabad, Gujarat, India – 380013.
As per the financials filed for FY 2019, the company reported a revenue of ₹10.71 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹2,772 (net margin 0.3%) and EBITDA of ₹7,511 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Prieks Pharmaceutical Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address790 – 1 Parshottamnagar Opp. Mun Bus Stand Nawa Wadaj, Ahmedabad, Gujarat, India – 380013
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Prieks Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prieks Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Prieks Pharmaceutical Private Limited, buy the company report.
Financials of Prieks Pharmaceutical Private Limited
FY 2019 filings availablePrieks Pharmaceutical Private Limited reported revenue of ₹10.71 Lakh (down 4% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹7,511 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2,772 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.7% | |||
| Net Profit Margin | 0.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Prieks Pharmaceutical Private Limited, buy the company report.
Board of directors of Prieks Pharmaceutical Private Limited
Prieks Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaileshbhai Hemrajbhai Chaudhary | Additional Director | 25 Jun 2020 | 6 Years 4 Months | Current |
| Hiruben Rameshbhai Chaudhary | Director | 01 Jun 2019 | 7 Years 5 Months | Current |
Peer comparison
Prieks Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Blue Rickshaw Private Limited | ₹10.72 Lakh (FY 2024) | -42.0% | New Delhi, Delhi, India | |||
| Sellersking Infotech Private Limited | ₹10.72 Lakh (FY 2024) | -16.0% | Garhbeta, West Bengal, India | |||
| Decicorn Futuristic Private Limited | ₹10.71 Lakh (FY 2024) | 6.0% | Kolkata, West Bengal, India | |||
| Trigger Automobiles India Private Limited | ₹10.71 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| GPK Investments Pvt Ltd | ₹10.71 Lakh (FY 2025) | 6.0% | Kolkata, West Bengal, India | |||
| Prieks Pharmaceutical Private Limitedthis company | ₹10.71 Lakh (FY 2019) | ₹2,772 | 0.3% | -4.0% | Ahmedabad, Gujarat, India | |
| Wayw Retail Private Limited | ₹10.71 Lakh (FY 2024) | 92.0% | Bangalore, Karnataka, India | |||
| Sandeep Medicare Private Limited | ₹10.71 Lakh (FY 2024) | 26.0% | Lucknow, Uttar Pradesh, India | |||
| Azolla Amritam Private Limited | ₹10.7 Lakh (FY 2025) | 6.0% | Varanasi, Uttar Pradesh, India | |||
| Whiteray Innovation Private Limited | ₹10.7 Lakh (FY 2022) | -72.0% | Delhi, India | |||
| Winrise Marketing Private Limited | ₹10.7 Lakh (FY 2021) | -6.0% | Delhi, India |
To see the full peer comparison of Prieks Pharmaceutical Private Limited, buy the company report.
Auditor
Prieks Pharmaceutical Private Limited is audited by MUKESH PATEL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH PATEL & ASSOCIATES | FY 2017 | 149615 |
Shareholding
The shareholding of Prieks Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Prieks Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Prieks Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prieks Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prieks Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICP2642L1ZA | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Prieks Pharmaceutical Private Limited, buy the company report.
Recent activity
Prieks Pharmaceutical Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Bharatbhai Vajabhai Chaudhary ceased to be Director on 26 Jun 2020.
Frequently asked questions
Prieks Pharmaceutical is an active private limited company based in Ahmedabad, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 July 2015 (11+ years old) and is registered under CIN U24230GJ2015PTC084003.
Prieks Pharmaceutical has 2 current directors:
- Shaileshbhai Hemrajbhai Chaudhary - Additional Director
- Hiruben Rameshbhai Chaudhary - Director
The latest financial statements of Prieks Pharmaceutical on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 25 September 2019. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Prieks Pharmaceutical is 24AAICP2642L1ZA, registered in Gujarat.
The CIN (Corporate Identification Number) of Prieks Pharmaceutical is U24230GJ2015PTC084003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prieks Pharmaceutical was incorporated on 30 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Prieks Pharmaceutical by revenue are Blue Rickshaw Private Limited, Sellersking Infotech Private Limited, Decicorn Futuristic Private Limited, Trigger Automobiles India Private Limited, GPK Investments Pvt Ltd and 5 more, all in the same principal business activity (retail trading).
Bharatbhai Vajabhai Chaudhary ceased to be Director on 26 Jun 2020. Shaileshbhai Hemrajbhai Chaudhary was appointed as Additional Director on 25 Jun 2020. Hiruben Rameshbhai Chaudhary ceased to be Additional Director on 23 Sep 2019. Prieks Pharmaceutical has 5 board changes on record in total.
The registered office of Prieks Pharmaceutical is at 790 – 1 Parshottamnagar Opp. Mun Bus Stand Nawa Wadaj, Ahmedabad, Gujarat, India – 380013.
Prieks Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Prieks Pharmaceutical is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
